<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Laboratory tools for diagnosis of malaria
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Laboratory tools for diagnosis of malaria
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Laboratory tools for diagnosis of malaria
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Heidi Hopkins, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Johanna Daily, MD, MSc
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Elinor L Baron, MD, DTMH
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Oct 12, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H2551512">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Prompt and accurate diagnosis of malaria is critical for implementation of appropriate treatment to reduce associated morbidity and mortality. Accurate detection of malaria is also important for epidemiologic screening and surveillance to inform malaria control strategies, for research purposes in testing efficacy of antimalarial drugs and vaccines, and for blood bank screening.
        </p>
        <p>
         Characteristics of a useful malaria diagnostic tool include the ability to definitively establish presence or absence of infection, determine which species of malaria is/are present, quantify parasitemia (ie, parasites per microliter of blood or percent red blood cells infected), detect low-level parasitemia, and allow monitoring of response to antimalarial therapy (including detection of recrudescence or relapse). Thus far, there is no single malaria diagnostic tool that meets all of these criteria. Test characteristics that are important for diagnosis vary depending on the epidemiology of infection and goals for control in the region where the test is used.
        </p>
        <p>
         Tools for diagnosis of malaria will be reviewed here. Issues related to the clinical approach to diagnosis of malaria, as well as issues related to the epidemiology, clinical manifestations, treatment, and prevention of malaria, are discussed separately:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5702.html" rel="external">
          "Malaria: Epidemiology, prevention, and control"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5709.html" rel="external">
          "Malaria: Clinical manifestations and diagnosis in nonpregnant adults and children"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5704.html" rel="external">
          "Treatment of uncomplicated falciparum malaria in nonpregnant adults and children"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5667.html" rel="external">
          "Treatment of severe malaria"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/4812.html" rel="external">
          "Malaria in pregnancy: Prevention and treatment"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5706.html" rel="external">
          "Non-falciparum malaria: P. vivax, P. ovale, and P. malariae"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/112633.html" rel="external">
          "Non-falciparum malaria: Plasmodium knowlesi"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H6885923">
         <span class="h1">
          GENERAL PRINCIPLES
         </span>
         <span class="headingEndMark">
          —
         </span>
         Tools for diagnosis of malaria include microscopy (visualization of parasites in stained blood smears) and rapid diagnostic tests (RDTs; which detect antigen or antibody). Smear examination via light microscopy is the standard tool for diagnosis of malaria; RDTs should be used if microscopy is not readily available. Molecular techniques for detection of genetic material are limited to research settings [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H23056286">
         <span class="h1">
          LIGHT MICROSCOPY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Detection of parasites on Giemsa-stained blood smears by light microscopy is the standard tool for diagnosis of malaria [
         <a href="#rid2">
          2
         </a>
         ]. In expert hands, the sensitivity of microscopy can be excellent, with detection of malaria parasites at densities as low as 4 to 20 parasites/mcL of blood (approximately 0.0001 to 0.0005 percent parasitemia) [
         <a href="#rid3">
          3-6
         </a>
         ]. Diagnostic errors occur more commonly in the setting of low-density parasitemia (10 to 100 parasites/mcL of blood), although errors can also occur with higher densities [
         <a href="#rid7">
          7-9
         </a>
         ].
        </p>
        <p>
         Microscopy allows identification of the
         <em>
          Plasmodium
         </em>
         species as well as quantification of parasitemia. It also enables diagnosis of hematologic abnormalities and other infectious diseases such as filariasis, trypanosomiasis, babesiosis, and others.
        </p>
        <p>
         Drawbacks to microscopy include that it is labor intensive and requires substantial training and expertise [
         <a href="#rid6">
          6,10,11
         </a>
         ]. The sensitivity and specificity of malaria microscopy in resource-limited settings is often below levels achievable in reference or research laboratories [
         <a href="#rid8">
          8,12-15
         </a>
         ]. In well-equipped laboratories outside of endemic areas, variation in techniques used for preparation and interpretation can influence results [
         <a href="#rid7">
          7,16-18
         </a>
         ], and errors may occur in laboratories with limited exposure to tropical infections [
         <a href="#rid2">
          2,19
         </a>
         ].
        </p>
        <p>
         Microscopy cannot reliably detect very low parasitemia (&lt;5 to 10 parasites/mcL) or cases where the majority of the parasite biomass is sequestered (eg, in the case of placental sequestration during pregnancy) [
         <a href="#rid10">
          10
         </a>
         ]. If malaria is suspected and the initial smear is negative, additional smears should be prepared and examined over the subsequent 48 to 72 hours. (See
         <a class="local">
          'Blood smear interpretation'
         </a>
         below.)
        </p>
        <p>
         In general, there is no role for routine use of pre-emptive treatment if quality-assured malaria diagnostic testing is negative. Presumptive treatment may be appropriate for circumstances in which prompt laboratory diagnosis is not available and clinical suspicion for severe disease is high.
        </p>
        <p>
         The sensitivity of light microscopy for detecting placental infection is low [
         <a href="#rid20">
          20-22
         </a>
         ]; in one study including more than 590 pregnant women in Ghana, the sensitivity of light microscopy, rapid antigen test, and polymerase chain reaction were 42, 80, and 97 percent, respectively [
         <a href="#rid20">
          20
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H23056293">
         <span class="h2">
          Blood smear preparation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Preparation of smears consists of applying a drop of blood to a glass microscopy slide, followed by drying and staining procedures. Capillary blood from a fingerprick (or ear lobe or infant heelstick) or anticoagulated venous blood may be used. Smears should be prepared as soon as possible after blood collection to avoid alteration in parasite morphology and staining properties.
        </p>
        <p>
         Two types of blood smears are used in malaria microscopy: thin and thick smears. Thin smear preparation maintains the integrity and morphology of erythrocytes so that parasites are visible within red blood cells. Thin smears allow identification of the infecting parasite species and can be used to measure parasite density. Thick smear preparation involves mechanical lysis of red blood cells so that malaria parasites can be visualized independent of cell structures. Thick smears allow the microscopist to review a relatively large quantity of blood and are typically used to screen for presence or absence of parasites and to estimate parasite density.
        </p>
        <p>
         The United States Centers for Disease Control and Prevention (CDC) has online guides for
         <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.cdc.gov%2Fdpdx%2Fresources%2Fpdf%2FbenchAids%2Fmalaria%2FMalaria_procedures_benchaid.pdf&amp;token=jP9irApsPmydY%2FPyZ5WZo4GaiowtUiAjdZMZ3C9yc%2BH3BdkG2InFpKDhBWky4U5AczBYQyDbR1vZ5hKorwm04oodmzEvBOJDIiufS7q%2FtUUv21Kr2iRKERETFpthSsiA&amp;TOPIC_ID=5707" target="_blank">
          preparation
         </a>
         and
         <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.cdc.gov%2Fdpdx%2Fresources%2Fpdf%2FbenchAids%2Fmalaria%2FMalaria_staining_benchaid.pdf&amp;token=OakZlLnjxZubL8zHgzJ7tY2nabqKECyKonBe2sbwjj2YPSFyjLaxJlBK1nWf1%2FxaTr%2FXLPfSm9LytXgQT2P6btasdEobAw%2FnZGfp78z8zvIcvyex4G8rTtbvc6MtVKOe&amp;TOPIC_ID=5707" target="_blank">
          staining
         </a>
         of blood smears.
        </p>
        <p class="headingAnchor" id="H23056300">
         <span class="h2">
          Blood smear interpretation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Malaria parasites are best seen under 100x magnification using the oil immersion objective lens; smear evaluation should include examination of at least 200 to 500 fields or examination for 20 to 30 minutes.
        </p>
        <p>
         If malaria is suspected and the initial smear is negative, additional smears should be prepared and examined over the subsequent 48 to 72 hours [
         <a href="#rid23">
          23
         </a>
         ]; the CDC recommends repeating a thick and thin smear every 12 to 24 hours for a total of three sets before ruling out malaria [
         <a href="#rid24">
          24,25
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2551518">
         <span class="h3">
          Species identification
         </span>
         <span class="headingEndMark">
          —
         </span>
         Thin smears allow identification of the malaria species. The malaria species morphology is variable depending on the stage of infection  (
         <a class="graphic graphic_figure graphicRef70176" href="/z/d/graphic/70176.html" rel="external">
          figure 1
         </a>
         and
         <a class="graphic graphic_figure graphicRef80296" href="/z/d/graphic/80296.html" rel="external">
          figure 2
         </a>
         and
         <a class="graphic graphic_table graphicRef53291" href="/z/d/graphic/53291.html" rel="external">
          table 1
         </a>
         and
         <a class="graphic graphic_table graphicRef77935" href="/z/d/graphic/77935.html" rel="external">
          table 2
         </a>
         ).
        </p>
        <p>
         The CDC has bench aids for identification of
         <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.cdc.gov%2Fdpdx%2Fresources%2Fpdf%2FbenchAids%2Fmalaria%2FPfalciparum_benchaidV2.pdf&amp;token=iZi3nNfSkYtH%2F64Xq2SlDFJJQ9gTLwVCf6nvgAIskhiZnYvnUa54PQQVHpzk2CZHPRj9vszuU2D1KmtSYoD6gPHd5C5OpBGQLQ0HmUmENRfV6qfy01YWaFtmkB98XGNE&amp;TOPIC_ID=5707" target="_blank">
          P. falciparum
         </a>
         ,
         <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.cdc.gov%2Fdpdx%2Fresources%2Fpdf%2FbenchAids%2Fmalaria%2FPvivax_benchaidV2.pdf&amp;token=1Acc491coYrRSxl5pHi9ZUefnymR%2FCQPAzNz0Gy70YMyJ%2FtJS93p4%2FStTsvlt63J0u9h7l%2BzQEmqFscqq2YEehk1MtqUKnqOvOtdbEXmT8A%3D&amp;TOPIC_ID=5707" target="_blank">
          P. vivax
         </a>
         ,
         <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.cdc.gov%2Fdpdx%2Fresources%2Fpdf%2FbenchAids%2Fmalaria%2FPovale_benchaidV2.pdf&amp;token=1Acc491coYrRSxl5pHi9ZThGFbfPVdD5WoEvwgiY5YKW%2FIGaGBDUfbAYitEJNDxt0RHEyDFxa%2BFaRT2OfMETy06QjvPagYLKxNxyO96eRKA%3D&amp;TOPIC_ID=5707" target="_blank">
          P. ovale
         </a>
         , and
         <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.cdc.gov%2Fdpdx%2Fresources%2Fpdf%2FbenchAids%2Fmalaria%2FPmalariae_benchaidV2.pdf&amp;token=mjmpv7xMHRIW2nr%2B3NCnsUP8qF%2B9A99amDY3GgwDxG4xbZuxdVZWyadWdF02hSPwQkANo%2FbB1st%2FR0t%2Bu%2FKqDss7XDFhN7QXYGZlmLbllOQ%3D&amp;TOPIC_ID=5707" target="_blank">
          P. malariae
         </a>
         .
        </p>
        <p>
         <em>
          Plasmodium knowlesi
         </em>
         , which may cause severe disease, may be indistinguishable by microscopy from
         <em>
          P. malariae
         </em>
         (which generally causes milder illness). (See
         <a class="medical medical_review" href="/z/d/html/112633.html" rel="external">
          "Non-falciparum malaria: Plasmodium knowlesi"
         </a>
         .)
        </p>
        <p>
         Administration of antimalarial therapy can alter the morphologic appearance of parasites and affect their identification in blood smears [
         <a href="#rid6">
          6,26,27
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H354392931">
         <span class="h3">
          Quantification of parasitemia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Parasitemia density may be quantified using a thin blood smear or a thick blood smear:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For thin blood smears, the parasite density can be estimated by examining a monolayer of red blood cells (RBCs) using the oil immersion objective at 100x. The slide should be examined where the RBCs are more or less touching (approximately 400 RBCs per field). The parasite density can then be estimated from the percentage of infected RBCs; at least 500 RBCs should be counted [
         <a href="#rid28">
          28
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For thick blood smears, a standard approach to estimating parasite density involves counting asexual parasite forms and white blood cells in each microscopy field until 200 white blood cells have been counted. If fewer than 10 asexual parasites are counted per 200 white blood cells, counting should continue to a total of 500 white blood cells. Subsequently, the measured white blood cell count (in cells per microL) is divided by the number of white blood cells counted (200 or 500), and the result is multiplied by the number of parasites counted, giving the parasite density (parasites per microL). Variation in white blood cell counts may confound estimates that use an average rather than a measured white blood count [
         <a href="#rid29">
          29
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         For example, a white blood cell count of 8000/microL divided by 200 white blood cells counted, times 500 parasites counted, gives a parasite density of 20,000 parasites/microL. An alternate expression of parasitemia is the percentage of erythrocytes that are parasitized. In this example, the percent parasitemia is 20,000 parasites/microL divided by 4,000,000 (the average number of erythrocytes per microL in human blood), or 0.5 percent.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         As another example, a white blood cell count of 5000/microL, divided by 500 white blood cells counted, times 5 parasites counted, gives a parasite density of 50 parasites/microL. The percent parasitemia is 50 divided by 4,000,000, or 0.001 percent.
        </p>
        <p>
        </p>
        <p>
         Only asexual parasite forms are counted in calculating the parasite density  (
         <a class="graphic graphic_figure graphicRef80296" href="/z/d/graphic/80296.html" rel="external">
          figure 2
         </a>
         ). The presence of gametocytes alone indicates a recent infection (and potential for mosquitoes taking a blood meal to become infected) but not infection with actively replicating malaria parasites, which may cause symptoms. Because gametocytes are less susceptible than asexual parasites to many antimalarial drugs, persistence of gametocytes alone following treatment does not indicate drug resistance [
         <a href="#rid25">
          25
         </a>
         ].
        </p>
        <p>
         <em>
          P. falciparum, P. malariae,
         </em>
         and
         <em>
          P. knowlesi
         </em>
         infect mature erythrocytes and therefore can mount relatively high parasite densities; a parasitemia of ≥5 percent is very unlikely with any species except
         <em>
          P. falciparum
         </em>
         .
         <em>
          P. vivax,
         </em>
         and
         <em>
          P. ovale
         </em>
         infect only young erythrocytes, so parasite density for these species is typically lower.
        </p>
        <p class="headingAnchor" id="H3226551877">
         <span class="h2">
          Uncomplicated versus severe malaria
         </span>
         <span class="headingEndMark">
          —
         </span>
         In general, the higher the parasite density, the higher the likelihood of severe malaria; this is particularly true for individuals who do not have partial immunity (such as travelers from non-malarious areas and residents of areas with low malaria transmission). However, this association is not observed in all cases, and the relationship between parasite density, total parasite biomass, patient immunity, and severity of presenting symptoms remains to be elucidated [
         <a href="#rid30">
          30
         </a>
         ].
        </p>
        <p>
         The World Health Organization definition of severe
         <em>
          P. falciparum
         </em>
         malaria includes hyperparasitemia (&gt;2 percent or 100,000 parasites/microL in low-intensity transmission areas or &gt;5 percent or 250,000 parasites/microL in areas of high stable malaria transmission intensity) [
         <a href="#rid31">
          31
         </a>
         ]. The CDC definition of severe malaria includes parasitemia of ≥5 percent [
         <a href="#rid24">
          24
         </a>
         ]. The peripheral blood smear may reflect a low parasite density relative to the parasite burden present, since parasites frequently sequester in capillaries in the setting of severe malaria.
        </p>
        <p class="headingAnchor" id="H23056321">
         <span class="h1">
          RAPID DIAGNOSTIC TESTS
         </span>
        </p>
        <p class="headingAnchor" id="H2692324428">
         <span class="h2">
          General principles
         </span>
         <span class="headingEndMark">
          —
         </span>
         Rapid diagnostic tests (RDTs) for detection of malaria parasite antigens have become important diagnostic tools in resource-limited endemic settings over the past decade due to their accuracy and ease of use. They require no electricity or laboratory infrastructure, give results within 15 to 20 minutes, and can be performed successfully even by health workers with limited training. RDTs provide a qualitative result but cannot provide quantitative information regarding parasite density. RDTs that detect antibodies produced by an infected host are also available; however, these are less useful for diagnosing acute infection.
        </p>
        <p>
         The approach to RDT selection depends on the epidemiology of infection and goals for control in the region where the test is used [
         <a href="#rid32">
          32
         </a>
         ]. In regions where infection is primarily caused by
         <em>
          P. falciparum
         </em>
         , use of an assay that detects
         <em>
          P. falciparum
         </em>
         only may be sufficient and cost-effective. In regions where falciparum and non-falciparum parasites coexist or where
         <em>
          P. vivax
         </em>
         predominates, use of an RDT that can detect and distinguish between these species is warranted  (
         <a class="graphic graphic_table graphicRef88872" href="/z/d/graphic/88872.html" rel="external">
          table 3
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H4941987">
         <span class="h2">
          Assay types
         </span>
         <span class="headingEndMark">
          —
         </span>
         RDTs based on antigen detection detect one or more of the following: histidine-rich protein 2 (HRP2; for detection of
         <em>
          P. falciparum
         </em>
         ),
         <em>
          Plasmodium
         </em>
         lactate dehydrogenase (pLDH; for detection of all species or specific detection of
         <em>
          P. falciparum
         </em>
         or
         <em>
          P. vivax
         </em>
         ), and aldolase (for detection of all species). Depending on the target antigen(s), an RDT may identify
         <em>
          Plasmodium
         </em>
         genus only or may distinguish
         <em>
          P. falciparum
         </em>
         and/or
         <em>
          P. vivax
         </em>
         infections.
        </p>
        <p>
         In general, for diagnosis of
         <em>
          P. falciparum
         </em>
         , RDTs that detect HRP2 are somewhat more sensitive than those that detect pLDH. For diagnosis of non-falciparum species, RDTs that detect pLDH and aldolase appear to be comparable.
        </p>
        <p>
         Most antigen-detecting RDTs are based on immunochromatographic lateral flow technology; they consist of a nitrocellulose wick packaged as a dipstick, plastic cassette, or paper card  (
         <a class="graphic graphic_figure graphicRef88871" href="/z/d/graphic/88871.html" rel="external">
          figure 3
         </a>
         ) [
         <a href="#rid6">
          6,10,11,33,34
         </a>
         ]. One end of the test strip contains labeled antibodies and an agent to lyse red blood cells; a blood sample (5 to 20 mcL) and buffer are placed there, and the liquid migrates along the strip via capillary action, together with the labeled antibodies. The strip also contains a test line (bound antibody that binds parasite antigen, if present) and a control line (bound antibody that binds the migrating-labeled antibody to confirm adequate flow). The development time is typically 15 to 20 minutes.
        </p>
        <p class="headingAnchor" id="H1613710376">
         <span class="h3">
          HRP2 (may detect P. falciparum)
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Detection of
         </strong>
         <strong>
          <em>
           P. falciparum
          </em>
         </strong>
         – Histidine-rich protein 2 (HRP2) is part of a family of
         <em>
          P. falciparum
         </em>
         histidine-rich proteins [
         <a href="#rid35">
          35
         </a>
         ]. It is only produced by
         <em>
          P. falciparum
         </em>
         ; therefore, use of HRP2-based RDTs is appropriate in regions where
         <em>
          P. falciparum
         </em>
         is the predominant species (eg, much of sub-Saharan Africa). Combination tests may be useful in areas endemic for multiple
         <em>
          Plasmodium
         </em>
         species.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         HRP2-based RDTs can detect lower levels of parasitemia than RDTs based on other target antigens [
         <a href="#rid36">
          36-41
         </a>
         ]. However, detectable HRP2 antigen may persist in the bloodstream for anywhere from a few days to several weeks after parasitemia is no longer present. In the absence of good quality confirmatory microscopy, there is currently no way to distinguish HRP2 antigenemia resulting from a new infection or persistent infection (ie, resulting from treatment failure) from antigenemia persisting from a recently treated infection. Some endemic countries' national guidelines therefore advise that a positive HRP2 result should be considered to represent a new infection only if the specimen was drawn 7 to 14 days or longer following a previously treated infection; however, it is recognized that this provides general guidance only and the duration of persistent antigenemia varies considerably among individual cases. Therefore, the usefulness of HRP2-based assays may be limited in areas of intense malaria transmission where positive results may occur as a result of prior infection. For the same reason, HRP2-based assays are not useful for monitoring following treatment [
         <a href="#rid42">
          42-46
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Interpreting negative HRP2 results
         </strong>
         – Variability in HRP2 gene sequence may affect test performance in some circumstances [
         <a href="#rid47">
          47-49
         </a>
         ]. Deletions in the genes encoding for HRP2 (and the similar HRP3 protein), leading to false-negative RDT results, have been identified in
         <em>
          P. falciparum
         </em>
         parasites from the Peruvian Amazon [
         <a href="#rid50">
          50,51
         </a>
         ] and Eritrea [
         <a href="#rid52">
          52
         </a>
         ]. Therefore, HRP2-based tests are not reliable for detection of malaria infection contracted in these areas.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Reports of
         <em>
          pfhrp2
         </em>
         and
         <em>
          pfhrp3
         </em>
         mutations or deletions have emerged in regions of Africa, Asia, and the Middle East, leading to false-negative RDT results in some cases [
         <a href="#rid53">
          53,54
         </a>
         ]. Strains with both
         <em>
          pfhrp2
         </em>
         and
         <em>
          pfhrp3
         </em>
         gene deletions are undetectable by HRP2-based RDTs; sometimes these assays can sometimes detect strains with only a
         <em>
          pfhrp2
         </em>
         deletion, especially in high-density infections, due to cross reactivity with HRP3 epitopes [
         <a href="#rid48">
          48
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The global distribution, frequency, and operational implications of these deletions are not yet fully understood [
         <a href="#rid55">
          55
         </a>
         ]. The World Health Organization (WHO) has identified the Horn of Africa as a region with high levels of
         <em>
          pfhrp2
         </em>
         deletions, and Eritrea moved its national policy away from use of HRP2-based RDTs in 2016. The WHO has issued epidemiologic and laboratory guidance for assessment of mutations, as well as a global action plan for surveillance and response [
         <a href="#rid48">
          48,53,56,57
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Rarely, false-negative HRP2 results may occur at very high levels of antigenemia or parasitemia due to a prozone-like effect [
         <a href="#rid49">
          49,58,59
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2358296399">
         <span class="h3">
          pLDH (may detect all species)
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          Plasmodium
         </em>
         lactate dehydrogenase (pLDH) is the terminal enzyme in the malaria parasite glycolytic pathway and is produced by asexual and sexual forms of all
         <em>
          Plasmodium
         </em>
         species [
         <a href="#rid60">
          60
         </a>
         ].
         <em>
          Plasmodium
         </em>
         LDH can be distinguished from human LDH on the basis of unique epitopes and enzymatic characteristics [
         <a href="#rid61">
          61,62
         </a>
         ].
        </p>
        <p>
         Two types of pLDH-based RDTs are available: those that target a conserved pLDH element in all human malaria species and those that target species-specific regions that distinguish
         <em>
          P. falciparum
         </em>
         or
         <em>
          P. vivax
         </em>
         . pLDH antibodies specific for
         <em>
          P. ovale
         </em>
         and
         <em>
          P. malariae
         </em>
         have been described but are not yet commercially available [
         <a href="#rid34">
          34
         </a>
         ].
        </p>
        <p>
         Serum pLDH levels correlate with parasite density and become undetectable at the same time blood smears become negative following antimalarial therapy [
         <a href="#rid62">
          62
         </a>
         ] so that pLDH-based assays may be used for monitoring following treatment and to diagnose treatment failure [
         <a href="#rid46">
          46,63-66
         </a>
         ].
        </p>
        <p>
         pLDH-based RDTs are less sensitive than HRP2-based tests for detection of
         <em>
          P. falciparum
         </em>
         infection, especially at relatively low parasite densities (&lt;500 parasites/mcL) [
         <a href="#rid36">
          36,39,67,68
         </a>
         ]. In highly endemic areas, this may have little clinical significance since patients with relatively low parasite densities are often asymptomatic.
        </p>
        <p>
         Antigenic variation does not appear to significantly affect pLDH-based detection of most parasite species [
         <a href="#rid69">
          69
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H392711152">
         <span class="h3">
          Aldolase (may detect all species)
         </span>
         <span class="headingEndMark">
          —
         </span>
         Aldolase is an enzyme in the malaria parasite glycolytic pathway that is conserved across all human malaria species. Serum aldolase levels correlate with parasite density and become undetectable with clearance of parasitemia.
        </p>
        <p>
         For detection of
         <em>
          P. falciparum
         </em>
         , the sensitivity of aldolase-based assays is generally somewhat lower than that of HRP2-based assays [
         <a href="#rid34">
          34,67,70-72
         </a>
         ]. For detection of non-falciparum infections, the sensitivity of aldolase and pLDH assays is comparable.
        </p>
        <p>
         Genetic diversity does not appear to be a factor in aldolase-based RDT accuracy [
         <a href="#rid73">
          73,74
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1052857">
         <span class="h2">
          Accuracy
         </span>
         <span class="headingEndMark">
          —
         </span>
         There are many different commercial RDT products available. Between 2009 and 2017, the WHO-FIND global RDT testing program conducted standardized laboratory evaluations of RDTs, including testing against well-characterized panels of parasites and antigens [
         <a href="#rid75">
          75
         </a>
         ]. Periodic reports from this program are available online and provided the most systematic and reliable information on accuracy of available malaria RDTs at any given time. As of 2018, the WHO switched to a "prequalification" program, and a list of prequalified malaria RDTs is maintained online [
         <a href="#rid76">
          76
         </a>
         ].
        </p>
        <p>
         The validity of individual reports on RDT accuracy must be considered in light of the parasite antigen(s) targeted, the comparison standard(s) used (routine microscopy, expert microscopy, polymerase chain reaction [PCR]), malaria epidemiology in the study area (including presence of
         <em>
          Plasmodium
         </em>
         species and level of transmission), the population in which the RDTs were evaluated, and the personnel performing the RDTs. Other factors influencing RDT accuracy include the type of antibody used (monoclonal versus polyclonal), the source of antigen used to induce the test antibodies, and the epitope targeted by test antibodies [
         <a href="#rid10">
          10,34
         </a>
         ].
        </p>
        <p>
         Given the volume and variety of data, any statement of RDT accuracy must include a number of caveats. A meta-analysis of RDT diagnosis for uncomplicated
         <em>
          P. falciparum
         </em>
         malaria in endemic countries (in comparison with microscopy) noted sensitivity and specificity of 93 to 98 percent for assays targeting HRP2 and pLDH [
         <a href="#rid77">
          77
         </a>
         ]. A separate meta-analysis of RDT diagnosis for travelers returning from endemic areas noted that for
         <em>
          P. falciparum
         </em>
         , tests utilizing HRP2 were more accurate than those utilizing pLDH (negative likelihood ratios 0.08 and 0.13, respectively) [
         <a href="#rid78">
          78
         </a>
         ]. Three-band HRP2 tests had similar negative likelihood ratios but higher positive likelihood ratios compared with two-band tests (34.7 versus 98.5; p = 0.003). Evidence was limited for species other than
         <em>
          P. falciparum
         </em>
         .
        </p>
        <p class="headingAnchor" id="H1054963">
         <span class="h2">
          Use
         </span>
        </p>
        <p class="headingAnchor" id="H873575231">
         <span class="h3">
          In endemic areas
         </span>
         <span class="headingEndMark">
          —
         </span>
         Use of RDTs in endemic areas has increased rapidly [
         <a href="#rid79">
          79
         </a>
         ]. Globally, the proportion of suspected malaria cases in the public health care sector who receive a parasitologic test has increased in most endemic regions since 2010; the greatest estimated rise, in Africa, was from 36 to 87 percent between 2010 and 2016, mostly due to an increase in RDT use [
         <a href="#rid79">
          79
         </a>
         ].
        </p>
        <p>
         However, the safety and acceptability of withholding antimalarial treatment from patients with negative RDT results remains an important concern [
         <a href="#rid31">
          31,80-82
         </a>
         ]; administration of presumptive antimalarial treatment for fever has long been a recommended standard of care in many endemic areas [
         <a href="#rid83">
          83-85
         </a>
         ]. Favorable outcomes for management for uncomplicated febrile illness in children based on RDT results have been observed in a number of endemic settings, including Benin [
         <a href="#rid86">
          86
         </a>
         ], Ghana [
         <a href="#rid87">
          87
         </a>
         ], Papua New Guinea [
         <a href="#rid88">
          88
         </a>
         ], Tanzania [
         <a href="#rid89">
          89,90
         </a>
         ], and Zambia [
         <a href="#rid91">
          91
         </a>
         ]. However, RDTs do not have adequate negative predictive value to justify withholding treatment in the setting of severe illness [
         <a href="#rid39">
          39,92,93
         </a>
         ].
        </p>
        <p>
         Use of RDTs for diagnosis of asymptomatic malaria in pregnancy is the subject of ongoing study [
         <a href="#rid94">
          94-97
         </a>
         ].
        </p>
        <p>
         Highly sensitive RDTs, also called ultrasensitive RDTs, detect parasite antigen at lower thresholds than conventional RDTs. These have been proposed for detection of asymptomatic parasitemia in malaria elimination programs. Highly sensitive RDTs detect more cases of low-level parasitemia than conventional RDTs but are less sensitive than molecular tests [
         <a href="#rid98">
          98-101
         </a>
         ]. (See
         <a class="local">
          'Molecular tests'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H1054970">
         <span class="h3">
          Outside endemic areas
         </span>
         <span class="headingEndMark">
          —
         </span>
         One RDT has been approved by the United States Food and Drug Administration (FDA): BinaxNOW Malaria. The test is a combination assay with antibodies for detection of HRP2 and aldolase.
        </p>
        <p>
         Among 256 febrile returned travelers, the sensitivity of BinaxNOW for the detection of
         <em>
          P. falciparum
         </em>
         and non–
         <em>
          P. falciparum
         </em>
         infection was 94 and 84 percent, respectively [
         <a href="#rid102">
          102
         </a>
         ]. Subsequent experience has confirmed excellent but not perfect performance. Both false-positive and false-negative test results have been described, the latter especially in cases with low parasite density and/or non-falciparum infections [
         <a href="#rid10">
          10,103-106
         </a>
         ]. The CDC advises that RDTs should be used with a positive control (stored blood containing
         <em>
          P. falciparum
         </em>
         ), and both negative and positive results should be confirmed with microscopy [
         <a href="#rid107">
          107
         </a>
         ].
        </p>
        <p>
         Interpretation of discordant results (between RDT and microscopy) depends on the clinical context and the assay used. For example:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A positive HRP2 RDT with negative microscopy may represent residual antigenemia after successful treatment; alternatively, such results may reflect incomplete treatment. These possibilities must be distinguished based clinical judgment.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A negative HRP2 RDT with positive microscopy may occur in the presence of
         <em>
          P. falciparum
         </em>
         parasites with pfhrp2/3 gene deletions.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A negative pLDH RDT with positive microscopy may represent a low-grade parasitemia below the RDT detection threshold.
        </p>
        <p>
        </p>
        <p>
         RDTs should not be used for screening donated blood, since the thresholds of detection are not sufficiently sensitive to detect low parasite density [
         <a href="#rid10">
          10,108
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3367856586">
         <span class="h3">
          Self use
         </span>
         <span class="headingEndMark">
          —
         </span>
         Use of RDTs by travelers for self-diagnosis may be acceptable if expert diagnosis is not immediately available; however, the diagnosis should be confirmed as soon as possible [
         <a href="#rid78">
          78,102,109-112
         </a>
         ]. In one study including more than 150 symptomatic British travelers, 9 percent failed to successfully perform a valid RDT for self-diagnosis; among those who did, the sensitivity and specificity were 97 and 95 percent, respectively (compared with microscopy) [
         <a href="#rid113">
          113
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H23059210">
         <span class="h1">
          MOLECULAR TESTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Use of molecular tests for malaria detection is generally limited to reference laboratories and is primarily for research and epidemiologic purposes [
         <a href="#rid114">
          114
         </a>
         ]. The United States Centers for Disease Control and Prevention offers polymerase chain reaction (PCR) confirmation of species and identification of drug resistance mutations for malaria cases diagnosed in the United States [
         <a href="#rid115">
          115
         </a>
         ].
        </p>
        <p>
         In clinical practice, if
         <em>
          P. knowlesi
         </em>
         is suspected on epidemiologic grounds, following microscopy to detect parasitemia, PCR should be used to confirm the species and determine the appropriate treatment. (See
         <a class="medical medical_review" href="/z/d/html/112633.html" rel="external">
          "Non-falciparum malaria: Plasmodium knowlesi"
         </a>
         .)
        </p>
        <p>
         Nucleic acid tests (eg, PCR) are typically used as a gold standard in efficacy studies for antimalarial drugs, vaccines, and evaluation of other diagnostic agents [
         <a href="#rid32">
          32,116,117
         </a>
         ]. The theoretical limit of detection for PCR has been estimated at 0.02 to 1 parasite/microL [
         <a href="#rid118">
          118
         </a>
         ]. Nested PCR is the most sensitive nucleic acid amplification technology; its sensitivity is 400 parasites/mL [
         <a href="#rid119">
          119,120
         </a>
         ]. Parasite deoxyribonucleic acid (DNA) may be amplified after extraction from small volumes (typically 50 to 200 mcL) of whole blood from dried blood spots stored on filter paper following extraction [
         <a href="#rid121">
          121,122
         </a>
         ]. Commonly used PCR assays target genus-specific and species-specific sequences of the 18S small-subunit ribosomal ribonucleic acid (RNA), circumsporozoite surface protein (a nuclear gene encoding a cysteine protease), and the cytochrome b gene [
         <a href="#rid6">
          6,123-126
         </a>
         ].
        </p>
        <p>
         Low-density malaria infections that are detectable by PCR but below the detection threshold of microscopy or rapid diagnostic tests can contribute to transmission [
         <a href="#rid9">
          9,127-134
         </a>
         ]. Accurate detection of low-density malaria infection is of increasing importance as some malaria-endemic areas move toward elimination [
         <a href="#rid135">
          135
         </a>
         ], with surveillance and screening playing larger roles in program management [
         <a href="#rid136">
          136-138
         </a>
         ]. However, the infrastructure and training required for use of PCR limits its utility for these applications.
        </p>
        <p>
         Loop-mediated isothermal amplification (LAMP) assays for detection of malaria parasite DNA are being developed to facilitate use of molecular technology in endemic areas [
         <a href="#rid139">
          139-144
         </a>
         ]. Use of LAMP for amplification of DNA occurs at a single temperature so does not require the thermocycler instrumentation necessary for PCR. LAMP generates 10
         <sup>
          9
         </sup>
         to 10
         <sup>
          10
         </sup>
         replicates in 15 to 60 minutes, and the resultant turbidity can be detected visually or by turbidimetry, without need for further manipulation. Use of LAMP assays with a variety of target sequences and processing methods has demonstrated variable sensitivity and specificity [
         <a href="#rid145">
          145-153
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1397475319">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/113035.html" rel="external">
          "Society guideline links: Malaria"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H23059224">
         <span class="h1">
          SUMMARY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The approach to diagnosis of malaria consists of clinical diagnosis and parasite diagnosis. Parasite-based confirmation should be pursued whenever malaria is suspected clinically. Forms of parasite diagnosis include light microscopy (visualization of parasites in stained blood samples), rapid diagnostic tests (RDTs; detecting antigen or antibody), and molecular techniques detecting parasite genetic material. (See
         <a class="local">
          'Introduction'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Detection of parasites on Giemsa-stained blood smears by light microscopy is the standard tool for diagnosis of malaria; it allows identification of the
         <em>
          Plasmodium
         </em>
         species as well as quantification of parasitemia. However, microscopy cannot reliably detect very low parasitemia (&lt;5 to 10 parasites/mcL); it is also labor intensive and requires substantial training and expertise. Issues related to smear preparation and interpretation are discussed in detail above. (See
         <a class="local">
          'Light microscopy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Rapid diagnostic tests for detection of malaria parasite antigens are becoming increasingly important diagnostic tools in resource-limited endemic settings due to their accuracy and ease of use. They require no electricity or laboratory infrastructure, give results within 15 to 20 minutes, and can be performed successfully even by health workers with limited training. RDTs provide a qualitative result but cannot provide quantitative information regarding parasite density. (See
         <a class="local">
          'Rapid diagnostic tests'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The approach to RDT selection depends on the epidemiology of infection and goals for control in the region where the test is used. In regions where infection is primarily caused by
         <em>
          P. falciparum
         </em>
         , use of an assay that detects
         <em>
          P. falciparum
         </em>
         only may be sufficient and cost-effective. In regions where falciparum and non-falciparum parasites coexist or where
         <em>
          P. vivax
         </em>
         predominates, use of an RDT that can detect and distinguish between these species is warranted  (
         <a class="graphic graphic_table graphicRef88872" href="/z/d/graphic/88872.html" rel="external">
          table 3
         </a>
         ). (See
         <a class="local">
          'Rapid diagnostic tests'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         RDTs detect one or more of the following antigens: histidine-rich protein 2 (HRP2),
         <em>
          Plasmodium
         </em>
         lactate dehydrogenase (pLDH), and aldolase. In general, for diagnosis of
         <em>
          P. falciparum
         </em>
         , RDTs that detect HRP2 are more sensitive than those that detect pLDH. Reliance on HRP2-based RDTs should be avoided in areas where
         <em>
          pfhrp2/3
         </em>
         deletions are prevalent including the Peruvian Amazon and Eritrea. For diagnosis of non-falciparum species, RDTs that detect pLDH and aldolase appear to be comparable (see
         <a class="local">
          'Assay types'
         </a>
         above).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Use of molecular tests for malaria detection is generally limited to reference laboratories and is primarily for research and epidemiologic purposes. Nucleic acid tests (eg, polymerase chain reaction) are typically used as a gold standard in efficacy studies for antimalarial drugs, vaccines, and evaluation of other diagnostic agents. Loop-mediated isothermal amplification for detection of malaria parasite DNA is being developed as a field assay to facilitate use of molecular technology in endemic areas. (See
         <a class="local">
          'Molecular tests'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H355694935">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges Dr. Clinton Murray, who contributed to an earlier version of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Bailey JW, Williams J, Bain BJ, et al. Guideline: the laboratory diagnosis of malaria. General Haematology Task Force of the British Committee for Standards in Haematology. Br J Haematol 2013; 163:573.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abanyie FA, Arguin PM, Gutman J. State of malaria diagnostic testing at clinical laboratories in the United States, 2010: a nationwide survey. Malar J 2011; 10:340.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dowling MA, Shute GT. A comparative study of thick and thin blood films in the diagnosis of scanty malaria parasitaemia. Bull World Health Organ 1966; 34:249.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bruce-Chwatt LJ. DNA probes for malaria diagnosis. Lancet 1984; 1:795.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Payne D. Use and limitations of light microscopy for diagnosing malaria at the primary health care level. Bull World Health Organ 1988; 66:621.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moody A. Rapid diagnostic tests for malaria parasites. Clin Microbiol Rev 2002; 15:66.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Milne LM, Kyi MS, Chiodini PL, Warhurst DC. Accuracy of routine laboratory diagnosis of malaria in the United Kingdom. J Clin Pathol 1994; 47:740.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kilian AH, Metzger WG, Mutschelknauss EJ, et al. Reliability of malaria microscopy in epidemiological studies: results of quality control. Trop Med Int Health 2000; 5:3.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Okell LC, Ghani AC, Lyons E, Drakeley CJ. Submicroscopic infection in Plasmodium falciparum-endemic populations: a systematic review and meta-analysis. J Infect Dis 2009; 200:1509.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Murray CK, Gasser RA Jr, Magill AJ, Miller RS. Update on rapid diagnostic testing for malaria. Clin Microbiol Rev 2008; 21:97.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wongsrichanalai C, Barcus MJ, Muth S, et al. A review of malaria diagnostic tools: microscopy and rapid diagnostic test (RDT). Am J Trop Med Hyg 2007; 77:119.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Malaria diagnosis: memorandum from a WHO meeting. Bull World Health Organ 1988; 66:575.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Coleman RE, Maneechai N, Rachaphaew N, et al. Comparison of field and expert laboratory microscopy for active surveillance for asymptomatic Plasmodium falciparum and Plasmodium vivax in western Thailand. Am J Trop Med Hyg 2002; 67:141.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reyburn H, Ruanda J, Mwerinde O, Drakeley C. The contribution of microscopy to targeting antimalarial treatment in a low transmission area of Tanzania. Malar J 2006; 5:4.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kahama-Maro J, D'Acremont V, Mtasiwa D, et al. Low quality of routine microscopy for malaria at different levels of the health system in Dar es Salaam. Malar J 2011; 10:332.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Warhurst DC, Williams JE. ACP Broadsheet no 148. July 1996. Laboratory diagnosis of malaria. J Clin Pathol 1996; 49:533.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thomson S, Lohmann RC, Crawford L, et al. External quality assessment in the examination of blood films for malarial parasites within Ontario, Canada. Arch Pathol Lab Med 2000; 124:57.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kettelhut MM, Chiodini PL, Edwards H, Moody A. External quality assessment schemes raise standards: evidence from the UKNEQAS parasitology subschemes. J Clin Pathol 2003; 56:927.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kain KC, Harrington MA, Tennyson S, Keystone JS. Imported malaria: prospective analysis of problems in diagnosis and management. Clin Infect Dis 1998; 27:142.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mockenhaupt FP, Ulmen U, von Gaertner C, et al. Diagnosis of placental malaria. J Clin Microbiol 2002; 40:306.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mockenhaupt FP, Rong B, Till H, et al. Submicroscopic Plasmodium falciparum infections in pregnancy in Ghana. Trop Med Int Health 2000; 5:167.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Adegnika AA, Verweij JJ, Agnandji ST, et al. Microscopic and sub-microscopic Plasmodium falciparum infection, but not inflammation caused by infection, is associated with low birth weight. Am J Trop Med Hyg 2006; 75:798.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           White NJ. The treatment of malaria. N Engl J Med 1996; 335:800.
          </a>
         </li>
         <li class="breakAll">
          Centers for Disease Control and Prevention. Treatment of Malaria: Guidelines For Clinicians (United States). Part 1: Reporting and Evaluation &amp; Diagnosis. http://www.cdc.gov/malaria/diagnosis_treatment/clinicians1.html (Accessed on January 04, 2021).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Griffith KS, Lewis LS, Mali S, Parise ME. Treatment of malaria in the United States: a systematic review. JAMA 2007; 297:2264.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Beaudoin RL, Aikawa M. Primaquine-induced changes in morphology of exoerythrocytic stages of malaria. Science 1968; 160:1233.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jiang JB, Jacobs G, Liang DS, Aikawa M. Qinghaosu-induced changes in the morphology of Plasmodium inui. Am J Trop Med Hyg 1985; 34:424.
          </a>
         </li>
         <li class="breakAll">
          Centers for Disease Control and Prevention. Treatment of Malaria: Guidelines for Clinicians (United States). https://www.cdc.gov/malaria/diagnosis_treatment/clinicians1.html (Accessed on January 04, 2021).
         </li>
         <li>
          <a class="nounderline abstract_t">
           McKenzie FE, Prudhomme WA, Magill AJ, et al. White blood cell counts and malaria. J Infect Dis 2005; 192:323.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gonçalves BP, Huang CY, Morrison R, et al. Parasite burden and severity of malaria in Tanzanian children. N Engl J Med 2014; 370:1799.
          </a>
         </li>
         <li class="breakAll">
          World Health Organization. Guidelines for malaria, 25 November 2022. https://www.who.int/publications/i/item/guidelines-for-malaria (Accessed on November 30, 2022).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bell D, Peeling RW, WHO-Regional Office for the Western Pacific/TDR. Evaluation of rapid diagnostic tests: malaria. Nat Rev Microbiol 2006; 4:S34.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wilson ML. Malaria rapid diagnostic tests. Clin Infect Dis 2012; 54:1637.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bell D, Wongsrichanalai C, Barnwell JW. Ensuring quality and access for malaria diagnosis: how can it be achieved? Nat Rev Microbiol 2006; 4:S7.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Howard RJ, Uni S, Aikawa M, et al. Secretion of a malarial histidine-rich protein (Pf HRP II) from Plasmodium falciparum-infected erythrocytes. J Cell Biol 1986; 103:1269.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hopkins H, Bebell L, Kambale W, et al. Rapid diagnostic tests for malaria at sites of varying transmission intensity in Uganda. J Infect Dis 2008; 197:510.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hopkins H, Kambale W, Kamya MR, et al. Comparison of HRP2- and pLDH-based rapid diagnostic tests for malaria with longitudinal follow-up in Kampala, Uganda. Am J Trop Med Hyg 2007; 76:1092.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rakotonirina H, Barnadas C, Raherijafy R, et al. Accuracy and reliability of malaria diagnostic techniques for guiding febrile outpatient treatment in malaria-endemic countries. Am J Trop Med Hyg 2008; 78:217.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hendriksen IC, Mtove G, Pedro AJ, et al. Evaluation of a PfHRP2 and a pLDH-based rapid diagnostic test for the diagnosis of severe malaria in 2 populations of African children. Clin Infect Dis 2011; 52:1100.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Heutmekers M, Gillet P, Cnops L, et al. Evaluation of the malaria rapid diagnostic test SDFK90: detection of both PfHRP2 and Pf-pLDH. Malar J 2012; 11:359.
          </a>
         </li>
         <li class="breakAll">
          World Health Organization. In vitro diagnostics and laboratory technology. https://www.who.int/diagnostics_laboratory/evaluations/pq-list/malaria/public_report/en/ (Accessed on January 05, 2021).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mayxay M, Pukrittayakamee S, Chotivanich K, et al. Persistence of Plasmodium falciparum HRP-2 in successfully treated acute falciparum malaria. Trans R Soc Trop Med Hyg 2001; 95:179.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tjitra E, Suprianto S, Dyer ME, et al. Detection of histidine rich protein 2 and panmalarial ICT Malaria Pf/Pv test antigens after chloroquine treatment of uncomplicated falciparum malaria does not reliably predict treatment outcome in eastern Indonesia. Am J Trop Med Hyg 2001; 65:593.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Singh N, Shukla MM. Short report: Field evaluation of posttreatment sensitivity for monitoring parasite clearance of Plasmodium falciparum malaria by use of the Determine Malaria pf test in central India. Am J Trop Med Hyg 2002; 66:314.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Swarthout TD, Counihan H, Senga RK, van den Broek I. Paracheck-Pf accuracy and recently treated Plasmodium falciparum infections: is there a risk of over-diagnosis? Malar J 2007; 6:58.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Houzé S, Boly MD, Le Bras J, et al. PfHRP2 and PfLDH antigen detection for monitoring the efficacy of artemisinin-based combination therapy (ACT) in the treatment of uncomplicated falciparum malaria. Malar J 2009; 8:211.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee N, Baker J, Andrews KT, et al. Effect of sequence variation in Plasmodium falciparum histidine- rich protein 2 on binding of specific monoclonal antibodies: Implications for rapid diagnostic tests for malaria. J Clin Microbiol 2006; 44:2773.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cheng Q, Gatton ML, Barnwell J, et al. Plasmodium falciparum parasites lacking histidine-rich protein 2 and 3: a review and recommendations for accurate reporting. Malar J 2014; 13:283.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gillet P, Mori M, Van Esbroeck M, et al. Assessment of the prozone effect in malaria rapid diagnostic tests. Malar J 2009; 8:271.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gamboa D, Ho MF, Bendezu J, et al. A large proportion of P. falciparum isolates in the Amazon region of Peru lack pfhrp2 and pfhrp3: implications for malaria rapid diagnostic tests. PLoS One 2010; 5:e8091.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maltha J, Gamboa D, Bendezu J, et al. Rapid diagnostic tests for malaria diagnosis in the Peruvian Amazon: impact of pfhrp2 gene deletions and cross-reactions. PLoS One 2012; 7:e43094.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mihreteab S, Platon L, Berhane A, et al. Increasing Prevalence of Artemisinin-Resistant HRP2-Negative Malaria in Eritrea. N Engl J Med 2023; 389:1191.
          </a>
         </li>
         <li class="breakAll">
          World Health Organization. World malaria report 2021. https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2021 (Accessed on February 07, 2022).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Berhane A, Russom M, Bahta I, et al. Rapid diagnostic tests failing to detect Plasmodium falciparum infections in Eritrea: an investigation of reported false negative RDT results. Malar J 2017; 16:105.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thomson R, Parr JB, Cheng Q, et al. Prevalence of Plasmodium falciparum lacking histidine-rich proteins 2 and 3: a systematic review. Bull World Health Organ 2020; 98:558.
          </a>
         </li>
         <li class="breakAll">
          World Health Organization. False-negative RDT results and implications of new reports of P. falciparum histidine-rich protein 2/3 gene deletions. https://www.who.int/publications/i/item/WHO-HTM-GMP-2017.18 (Accessed on February 09, 2022).
         </li>
         <li class="breakAll">
          World Health Organization. Malaria threats map. https://apps.who.int/malaria/maps/threats/?theme=prevention&amp;mapType=prevention%3A0&amp;bounds=%5B%5B-141.20038536818964%2C-49.73101842186031%5D%2C%5B141.2003853681893%2C75.09074653131896%5D%5D&amp;insecticideClass=PYRETHROIDS&amp;insecticideTypes=&amp;assayTypes=MOLECULAR_ASSAY%2CBIOCHEMICAL_ASSAY%2CSYNERGIST-INSEC (Accessed on February 09, 2022).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gillet P, Scheirlinck A, Stokx J, et al. Prozone in malaria rapid diagnostics tests: how many cases are missed? Malar J 2011; 10:166.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Luchavez J, Baker J, Alcantara S, et al. Laboratory demonstration of a prozone-like effect in HRP2-detecting malaria rapid diagnostic tests: implications for clinical management. Malar J 2011; 10:286.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Makler MT, Piper RC, Milhous WK. Lactate dehydrogenase and the diagnosis of malaria. Parasitol Today 1998; 14:376.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vander Jagt DL, Hunsaker LA, Heidrich JE. Partial purification and characterization of lactate dehydrogenase from Plasmodium falciparum. Mol Biochem Parasitol 1981; 4:255.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Makler MT, Hinrichs DJ. Measurement of the lactate dehydrogenase activity of Plasmodium falciparum as an assessment of parasitemia. Am J Trop Med Hyg 1993; 48:205.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Makler MT, Ries JM, Williams JA, et al. Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity. Am J Trop Med Hyg 1993; 48:739.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oduola AM, Omitowoju GO, Sowunmi A, et al. Plasmodium falciparum: evaluation of lactate dehydrogenase in monitoring therapeutic responses to standard antimalarial drugs in Nigeria. Exp Parasitol 1997; 87:283.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Piper R, Lebras J, Wentworth L, et al. Immunocapture diagnostic assays for malaria using Plasmodium lactate dehydrogenase (pLDH). Am J Trop Med Hyg 1999; 60:109.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moody A, Hunt-Cooke A, Gabbett E, Chiodini P. Performance of the OptiMAL malaria antigen capture dipstick for malaria diagnosis and treatment monitoring at the Hospital for Tropical Diseases, London. Br J Haematol 2000; 109:891.
          </a>
         </li>
         <li class="breakAll">
          World Health Organization (WHO), the Foundation for Innovative New Diagnostics (FIND), and the United States Centers for Disease Control and Prevention (CDC). Malaria rapid diagnostic test performance. Results of WHO product testing of malaria RDTs: round 7 (2015-2016). http://www.who.int/malaria/publications/atoz/978924151268/en/ (Accessed on January 04, 2021).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Craig MH, Bredenkamp BL, Williams CH, et al. Field and laboratory comparative evaluation of ten rapid malaria diagnostic tests. Trans R Soc Trop Med Hyg 2002; 96:258.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Talman AM, Duval L, Legrand E, et al. Evaluation of the intra- and inter-specific genetic variability of Plasmodium lactate dehydrogenase. Malar J 2007; 6:140.
          </a>
         </li>
         <li class="breakAll">
          TDR/World Health Organization &amp; FIND. Malaria Rapid Diagnostic Test Performance: Summary results of WHO product testing of malaria RDTs: Round 1-4 2008-2012. Geneva, Switzerland, TDR/WHO, FIND, CDC.  2012
         </li>
         <li>
          <a class="nounderline abstract_t">
           Richter J, Göbels K, Müller-Stöver I, et al. Co-reactivity of plasmodial histidine-rich protein 2 and aldolase on a combined immuno-chromographic-malaria dipstick (ICT) as a potential semi-quantitative marker of high Plasmodium falciparum parasitaemia. Parasitol Res 2004; 94:384.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chou M, Kim S, Khim N, et al. Performance of "VIKIA Malaria Ag Pf/Pan" (IMACCESS®), a new malaria rapid diagnostic test for detection of symptomatic malaria infections. Malar J 2012; 11:295.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee N, Baker J, Bell D, et al. Assessing the genetic diversity of the aldolase genes of Plasmodium falciparum and Plasmodium vivax and its potential effect on performance of aldolase-detecting rapid diagnostic tests. J Clin Microbiol 2006; 44:4547.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cho CH, Nam MH, Kim JS, et al. Genetic variability in Plasmodium vivax aldolase gene in Korean isolates and the sensitivity of the Binax Now malaria test. Trop Med Int Health 2011; 16:223.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cunningham J, Jones S, Gatton ML, et al. A review of the WHO malaria rapid diagnostic test product testing programme (2008-2018): performance, procurement and policy. Malar J 2019; 18:387.
          </a>
         </li>
         <li class="breakAll">
          World Health Organization. Prequalified In Vitro Diagnostics. https://extranet.who.int/pqweb/vitro-diagnostics/vitro-diagnostics-lists (Accessed on February 09, 2022).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abba K, Kirkham AJ, Olliaro PL, et al. Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries. Cochrane Database Syst Rev 2014; :CD011431.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pulford J, Mueller I, Siba PM, Hetzel MW. Malaria case management in Papua New Guinea prior to the introduction of a revised treatment protocol. Malar J 2012; 11:157.
          </a>
         </li>
         <li class="breakAll">
          World Health Organization. World malaria report 2020. https://www.who.int/publications/i/item/9789240015791 (Accessed on November 10, 2021).
         </li>
         <li>
          <a class="nounderline abstract_t">
           English M, Reyburn H, Goodman C, Snow RW. Abandoning presumptive antimalarial treatment for febrile children aged less than five years--a case of running before we can walk? PLoS Med 2009; 6:e1000015.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           D'Acremont V, Lengeler C, Mshinda H, et al. Time to move from presumptive malaria treatment to laboratory-confirmed diagnosis and treatment in African children with fever. PLoS Med 2009; 6:e252.
          </a>
         </li>
         <li class="breakAll">
          WHO. The role of laboratory diagnosis to support malaria disease management: Focus on the use of rapid diagnostic tests in areas of high transmission; Report of a WHO technical consultation, 25-26 Oct 2004. Geneva, Switzerland, World Health Organization 2004/2006.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ndyomugyenyi R, Magnussen P, Clarke S. Diagnosis and treatment of malaria in peripheral health facilities in Uganda: findings from an area of low transmission in south-western Uganda. Malar J 2007; 6:39.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ndyomugyenyi R, Magnussen P, Clarke S. Malaria treatment-seeking behaviour and drug prescription practices in an area of low transmission in Uganda: implications for prevention and control. Trans R Soc Trop Med Hyg 2007; 101:209.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McCombie SC. Treatment seeking for malaria: a review of recent research. Soc Sci Med 1996; 43:933.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Faucher JF, Makoutode P, Abiou G, et al. Can treatment of malaria be restricted to parasitologically confirmed malaria? A school-based study in Benin in children with and without fever. Malar J 2010; 9:104.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ansah EK, Narh-Bana S, Epokor M, et al. Rapid testing for malaria in settings where microscopy is available and peripheral clinics where only presumptive treatment is available: a randomised controlled trial in Ghana. BMJ 2010; 340:c930.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Senn N, Rarau P, Manong D, et al. Rapid diagnostic test-based management of malaria: an effectiveness study in Papua New Guinean infants with Plasmodium falciparum and Plasmodium vivax malaria. Clin Infect Dis 2012; 54:644.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           d'Acremont V, Malila A, Swai N, et al. Withholding antimalarials in febrile children who have a negative result for a rapid diagnostic test. Clin Infect Dis 2010; 51:506.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mtove G, Hendriksen IC, Amos B, et al. Treatment guided by rapid diagnostic tests for malaria in Tanzanian children: safety and alternative bacterial diagnoses. Malar J 2011; 10:290.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chanda P, Hamainza B, Moonga HB, et al. Community case management of malaria using ACT and RDT in two districts in Zambia: achieving high adherence to test results using community health workers. Malar J 2011; 10:158.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mtove G, Nadjm B, Amos B, et al. Use of an HRP2-based rapid diagnostic test to guide treatment of children admitted to hospital in a malaria-endemic area of north-east Tanzania. Trop Med Int Health 2011; 16:545.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Manning L, Laman M, Rosanas-Urgell A, et al. Rapid antigen detection tests for malaria diagnosis in severely ill Papua New Guinean children: a comparative study using Bayesian latent class models. PLoS One 2012; 7:e48701.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tagbor H, Bruce J, Agbo M, et al. Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: a randomised controlled non-inferiority trial. PLoS One 2010; 5:e14425.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kattenberg JH, Tahita CM, Versteeg IA, et al. Evaluation of antigen detection tests, microscopy, and polymerase chain reaction for diagnosis of malaria in peripheral blood in asymptomatic pregnant women in Nanoro, Burkina Faso. Am J Trop Med Hyg 2012; 87:251.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Williams JE, Cairns M, Njie F, et al. The Performance of a Rapid Diagnostic Test in Detecting Malaria Infection in Pregnant Women and the Impact of Missed Infections. Clin Infect Dis 2016; 62:837.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Desai M, Gutman J, L'lanziva A, et al. Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomised controlled superiority trial. Lancet 2015; 386:2507.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Das S, Jang IK, Barney B, et al. Performance of a High-Sensitivity Rapid Diagnostic Test for Plasmodium falciparum Malaria in Asymptomatic Individuals from Uganda and Myanmar and Naive Human Challenge Infections. Am J Trop Med Hyg 2017; 97:1540.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mwesigwa J, Slater H, Bradley J, et al. Field performance of the malaria highly sensitive rapid diagnostic test in a setting of varying malaria transmission. Malar J 2019; 18:288.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Girma S, Cheaveau J, Mohon AN, et al. Prevalence and Epidemiological Characteristics of Asymptomatic Malaria Based on Ultrasensitive Diagnostics: A Cross-sectional Study. Clin Infect Dis 2019; 69:1003.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Slater HC, Ding XC, Knudson S, et al. Performance and utility of more highly sensitive malaria rapid diagnostic tests. BMC Infect Dis 2022; 22:121.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Farcas GA, Zhong KJ, Lovegrove FE, et al. Evaluation of the Binax NOW ICT test versus polymerase chain reaction and microscopy for the detection of malaria in returned travelers. Am J Trop Med Hyg 2003; 69:589.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Durand F, Crassous B, Fricker-Hidalgo H, et al. Performance of the Now Malaria rapid diagnostic test with returned travellers: a 2-year retrospective study in a French teaching hospital. Clin Microbiol Infect 2005; 11:903.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stauffer WM, Cartwright CP, Olson DA, et al. Diagnostic performance of rapid diagnostic tests versus blood smears for malaria in US clinical practice. Clin Infect Dis 2009; 49:908.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dimaio MA, Pereira IT, George TI, Banaei N. Performance of BinaxNOW for diagnosis of malaria in a U.S. hospital. J Clin Microbiol 2012; 50:2877.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bobenchik A, Shimizu-Cohen R, Humphries RM. Use of rapid diagnostic tests for diagnosis of malaria in the United States. J Clin Microbiol 2013; 51:379.
          </a>
         </li>
         <li class="breakAll">
          Centers for Disease Control and Prevention. Malaria Diagnosis (U.S.) – Rapid Diagnostic Test. http://www.cdc.gov/malaria/diagnosis_treatment/rdt.html (Accessed on January 04, 2021).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Seed CR, Kitchen A, Davis TM. The current status and potential role of laboratory testing to prevent transfusion-transmitted malaria. Transfus Med Rev 2005; 19:229.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Humar A, Ohrt C, Harrington MA, et al. Parasight F test compared with the polymerase chain reaction and microscopy for the diagnosis of Plasmodium falciparum malaria in travelers. Am J Trop Med Hyg 1997; 56:44.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jelinek T, Grobusch MP, Nothdurft HD. Use of dipstick tests for the rapid diagnosis of malaria in nonimmune travelers. J Travel Med 2000; 7:175.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rossi IA, D'Acremont V, Prod'Hom G, Genton B. Safety of falciparum malaria diagnostic strategy based on rapid diagnostic tests in returning travellers and migrants: a retrospective study. Malar J 2012; 11:377.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jelinek T, Amsler L, Grobusch MP, Nothdurft HD. Self-use of rapid tests for malaria diagnosis by tourists. Lancet 1999; 354:1609.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Whitty CJM, Armstrong M, Behrens RH. Self-testing for falciparum malaria with antigen-capture cards by travelers with symptoms of malaria. Am J Trop Med Hyg 2000; 63:295.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Proux S, Suwanarusk R, Barends M, et al. Considerations on the use of nucleic acid-based amplification for malaria parasite detection. Malar J 2011; 10:323.
          </a>
         </li>
         <li class="breakAll">
          Centers for Disease Control and Prevention. CDC Now Provides Malaria Drug Resistance Testing Services. http://www.cdc.gov/malaria/features/ars.html (Accessed on January 04, 2021).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mugittu K, Adjuik M, Snounou G, et al. Molecular genotyping to distinguish between recrudescents and new infections in treatment trials of Plasmodium falciparum malaria conducted in Sub-Saharan Africa: adjustment of parasitological outcomes and assessment of genotyping effectiveness. Trop Med Int Health 2006; 11:1350.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Imoukhuede EB, Andrews L, Milligan P, et al. Low-level malaria infections detected by a sensitive polymerase chain reaction assay and use of this technique in the evaluation of malaria vaccines in an endemic area. Am J Trop Med Hyg 2007; 76:486.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Babiker HA, Schneider P, Reece SE. Gametocytes: insights gained during a decade of molecular monitoring. Trends Parasitol 2008; 24:525.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Snounou G, Viriyakosol S, Jarra W, et al. Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections. Mol Biochem Parasitol 1993; 58:283.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mixson-Hayden T, Lucchi NW, Udhayakumar V. Evaluation of three PCR-based diagnostic assays for detecting mixed Plasmodium infection. BMC Res Notes 2010; 3:88.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Singh B, Cox-Singh J, Miller AO, et al. Detection of malaria in Malaysia by nested polymerase chain reaction amplification of dried blood spots on filter papers. Trans R Soc Trop Med Hyg 1996; 90:519.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Singh B, Bobogare A, Cox-Singh J, et al. A genus- and species-specific nested polymerase chain reaction malaria detection assay for epidemiologic studies. Am J Trop Med Hyg 1999; 60:687.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Snounou G, Viriyakosol S, Zhu XP, et al. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Mol Biochem Parasitol 1993; 61:315.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Conway DJ. Molecular epidemiology of malaria. Clin Microbiol Rev 2007; 20:188.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Farrugia C, Cabaret O, Botterel F, et al. Cytochrome b gene quantitative PCR for diagnosing Plasmodium falciparum infection in travelers. J Clin Microbiol 2011; 49:2191.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cordray MS, Richards-Kortum RR. Emerging nucleic acid-based tests for point-of-care detection of malaria. Am J Trop Med Hyg 2012; 87:223.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Roper C, Elhassan IM, Hviid L, et al. Detection of very low level Plasmodium falciparum infections using the nested polymerase chain reaction and a reassessment of the epidemiology of unstable malaria in Sudan. Am J Trop Med Hyg 1996; 54:325.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Toma H, Kobayashi J, Vannachone B, et al. A field study on malaria prevalence in southeastern Laos by polymerase chain reaction assay. Am J Trop Med Hyg 2001; 64:257.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alves FP, Durlacher RR, Menezes MJ, et al. High prevalence of asymptomatic Plasmodium vivax and Plasmodium falciparum infections in native Amazonian populations. Am J Trop Med Hyg 2002; 66:641.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zakeri S, Najafabadi ST, Zare A, Djadid ND. Detection of malaria parasites by nested PCR in south-eastern, Iran: evidence of highly mixed infections in Chahbahar district. Malar J 2002; 1:2.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Steenkeste N, Incardona S, Chy S, et al. Towards high-throughput molecular detection of Plasmodium: new approaches and molecular markers. Malar J 2009; 8:86.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schneider P, Bousema JT, Gouagna LC, et al. Submicroscopic Plasmodium falciparum gametocyte densities frequently result in mosquito infection. Am J Trop Med Hyg 2007; 76:470.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ouédraogo AL, Bousema T, Schneider P, et al. Substantial contribution of submicroscopical Plasmodium falciparum gametocyte carriage to the infectious reservoir in an area of seasonal transmission. PLoS One 2009; 4:e8410.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Manjurano A, Okell L, Lukindo T, et al. Association of sub-microscopic malaria parasite carriage with transmission intensity in north-eastern Tanzania. Malar J 2011; 10:370.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Feachem RG, Phillips AA, Hwang J, et al. Shrinking the malaria map: progress and prospects. Lancet 2010; 376:1566.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moonen B, Cohen JM, Snow RW, et al. Operational strategies to achieve and maintain malaria elimination. Lancet 2010; 376:1592.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mueller I, Slutsker L, Tanner M. Estimating the burden of malaria: the need for improved surveillance. PLoS Med 2011; 8:e1001144.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hsiang MS, Hwang J, Kunene S, et al. Surveillance for malaria elimination in Swaziland: a national cross-sectional study using pooled PCR and serology. PLoS One 2012; 7:e29550.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Notomi T, Okayama H, Masubuchi H, et al. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res 2000; 28:E63.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Poon LL, Wong BW, Ma EH, et al. Sensitive and inexpensive molecular test for falciparum malaria: detecting Plasmodium falciparum DNA directly from heat-treated blood by loop-mediated isothermal amplification. Clin Chem 2006; 52:303.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hopkins H, González IJ, Polley SD, et al. Highly sensitive detection of malaria parasitemia in a malaria-endemic setting: performance of a new loop-mediated isothermal amplification kit in a remote clinic in Uganda. J Infect Dis 2013; 208:645.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Patel JC, Lucchi NW, Srivastava P, et al. Field evaluation of a real-time fluorescence loop-mediated isothermal amplification assay, RealAmp, for the diagnosis of malaria in Thailand and India. J Infect Dis 2014; 210:1180.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Perera RS, Ding XC, Tully F, et al. Development and clinical performance of high throughput loop-mediated isothermal amplification for detection of malaria. PLoS One 2017; 12:e0171126.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Serra-Casas E, Manrique P, Ding XC, et al. Loop-mediated isothermal DNA amplification for asymptomatic malaria detection in challenging field settings: Technical performance and pilot implementation in the Peruvian Amazon. PLoS One 2017; 12:e0185742.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Paris DH, Imwong M, Faiz AM, et al. Loop-mediated isothermal PCR (LAMP) for the diagnosis of falciparum malaria. Am J Trop Med Hyg 2007; 77:972.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pöschl B, Waneesorn J, Thekisoe O, et al. Comparative diagnosis of malaria infections by microscopy, nested PCR, and LAMP in northern Thailand. Am J Trop Med Hyg 2010; 83:56.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sirichaisinthop J, Buates S, Watanabe R, et al. Evaluation of loop-mediated isothermal amplification (LAMP) for malaria diagnosis in a field setting. Am J Trop Med Hyg 2011; 85:594.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Polley SD, Mori Y, Watson J, et al. Mitochondrial DNA targets increase sensitivity of malaria detection using loop-mediated isothermal amplification. J Clin Microbiol 2010; 48:2866.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Polley SD, González IJ, Mohamed D, et al. Clinical evaluation of a loop-mediated amplification kit for diagnosis of imported malaria. J Infect Dis 2013; 208:637.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Piera KA, Aziz A, William T, et al. Detection of Plasmodium knowlesi, Plasmodium falciparum and Plasmodium vivax using loop-mediated isothermal amplification (LAMP) in a co-endemic area in Malaysia. Malar J 2017; 16:29.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Katrak S, Murphy M, Nayebare P, et al. Performance of Loop-Mediated Isothermal Amplification for the Identification of Submicroscopic Plasmodium falciparum Infection in Uganda. Am J Trop Med Hyg 2017; 97:1777.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Picot S, Cucherat M, Bienvenu AL. Systematic review and meta-analysis of diagnostic accuracy of loop-mediated isothermal amplification (LAMP) methods compared with microscopy, polymerase chain reaction and rapid diagnostic tests for malaria diagnosis. Int J Infect Dis 2020; 98:408.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morris U, Aydin-Schmidt B. Performance and Application of Commercially Available Loop-Mediated Isothermal Amplification (LAMP) Kits in Malaria Endemic and Non-Endemic Settings. Diagnostics (Basel) 2021; 11.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 5707 Version 51.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24219330" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Guideline: the laboratory diagnosis of malaria. General Haematology Task Force of the British Committee for Standards in Haematology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22074250" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : State of malaria diagnostic testing at clinical laboratories in the United States, 2010: a nationwide survey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5296131" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : A comparative study of thick and thin blood films in the diagnosis of scanty malaria parasitaemia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6143111" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : DNA probes for malaria diagnosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2463112" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Use and limitations of light microscopy for diagnosing malaria at the primary health care level.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11781267" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Rapid diagnostic tests for malaria parasites.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7962629" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Accuracy of routine laboratory diagnosis of malaria in the United Kingdom.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10672199" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Reliability of malaria microscopy in epidemiological studies: results of quality control.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19848588" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Submicroscopic infection in Plasmodium falciparum-endemic populations: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18202438" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Update on rapid diagnostic testing for malaria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18165483" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : A review of malaria diagnostic tools: microscopy and rapid diagnostic test (RDT).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3061674" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Malaria diagnosis: memorandum from a WHO meeting.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12389937" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Comparison of field and expert laboratory microscopy for active surveillance for asymptomatic Plasmodium falciparum and Plasmodium vivax in western Thailand.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16423307" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : The contribution of microscopy to targeting antimalarial treatment in a low transmission area of Tanzania.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22047131" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Low quality of routine microscopy for malaria at different levels of the health system in Dar es Salaam.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8813948" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : ACP Broadsheet no 148. July 1996. Laboratory diagnosis of malaria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10629133" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : External quality assessment in the examination of blood films for malarial parasites within Ontario, Canada.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14645352" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : External quality assessment schemes raise standards: evidence from the UKNEQAS parasitology subschemes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9675468" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Imported malaria: prospective analysis of problems in diagnosis and management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11773140" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Diagnosis of placental malaria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10747278" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Submicroscopic Plasmodium falciparum infections in pregnancy in Ghana.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17123968" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Microscopic and sub-microscopic Plasmodium falciparum infection, but not inflammation caused by infection, is associated with low birth weight.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8703186" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : The treatment of malaria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8703186" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : The treatment of malaria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17519416" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Treatment of malaria in the United States: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5648260" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Primaquine-induced changes in morphology of exoerythrocytic stages of malaria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3890573" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Qinghaosu-induced changes in the morphology of Plasmodium inui.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3890573" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Qinghaosu-induced changes in the morphology of Plasmodium inui.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15962228" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : White blood cell counts and malaria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24806160" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Parasite burden and severity of malaria in Tanzanian children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24806160" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Parasite burden and severity of malaria in Tanzanian children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17034070" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Evaluation of rapid diagnostic tests: malaria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22550113" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Malaria rapid diagnostic tests.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17003770" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Ensuring quality and access for malaria diagnosis: how can it be achieved?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3533951" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Secretion of a malarial histidine-rich protein (Pf HRP II) from Plasmodium falciparum-infected erythrocytes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18240951" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Rapid diagnostic tests for malaria at sites of varying transmission intensity in Uganda.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17556616" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Comparison of HRP2- and pLDH-based rapid diagnostic tests for malaria with longitudinal follow-up in Kampala, Uganda.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18256418" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Accuracy and reliability of malaria diagnostic techniques for guiding febrile outpatient treatment in malaria-endemic countries.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21467015" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Evaluation of a PfHRP2 and a pLDH-based rapid diagnostic test for the diagnosis of severe malaria in 2 populations of African children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23107162" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Evaluation of the malaria rapid diagnostic test SDFK90: detection of both PfHRP2 and Pf-pLDH.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23107162" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Evaluation of the malaria rapid diagnostic test SDFK90: detection of both PfHRP2 and Pf-pLDH.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11355555" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Persistence of Plasmodium falciparum HRP-2 in successfully treated acute falciparum malaria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11716120" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Detection of histidine rich protein 2 and panmalarial ICT Malaria Pf/Pv test antigens after chloroquine treatment of uncomplicated falciparum malaria does not reliably predict treatment outcome in eastern Indonesia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12139227" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Short report: Field evaluation of posttreatment sensitivity for monitoring parasite clearance of Plasmodium falciparum malaria by use of the Determine Malaria pf test in central India.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17506881" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Paracheck-Pf accuracy and recently treated Plasmodium falciparum infections: is there a risk of over-diagnosis?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19735557" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : PfHRP2 and PfLDH antigen detection for monitoring the efficacy of artemisinin-based combination therapy (ACT) in the treatment of uncomplicated falciparum malaria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16891491" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Effect of sequence variation in Plasmodium falciparum histidine- rich protein 2 on binding of specific monoclonal antibodies: Implications for rapid diagnostic tests for malaria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25052298" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Plasmodium falciparum parasites lacking histidine-rich protein 2 and 3: a review and recommendations for accurate reporting.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19948018" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Assessment of the prozone effect in malaria rapid diagnostic tests.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20111602" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : A large proportion of P. falciparum isolates in the Amazon region of Peru lack pfhrp2 and pfhrp3: implications for malaria rapid diagnostic tests.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22952633" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Rapid diagnostic tests for malaria diagnosis in the Peruvian Amazon: impact of pfhrp2 gene deletions and cross-reactions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37754284" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Increasing Prevalence of Artemisinin-Resistant HRP2-Negative Malaria in Eritrea.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37754284" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Increasing Prevalence of Artemisinin-Resistant HRP2-Negative Malaria in Eritrea.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28264689" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Rapid diagnostic tests failing to detect Plasmodium falciparum infections in Eritrea: an investigation of reported false negative RDT results.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32773901" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Prevalence of Plasmodium falciparum lacking histidine-rich proteins 2 and 3: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32773901" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Prevalence of Plasmodium falciparum lacking histidine-rich proteins 2 and 3: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32773901" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Prevalence of Plasmodium falciparum lacking histidine-rich proteins 2 and 3: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21676264" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Prozone in malaria rapid diagnostics tests: how many cases are missed?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21957869" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Laboratory demonstration of a prozone-like effect in HRP2-detecting malaria rapid diagnostic tests: implications for clinical management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17040820" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Lactate dehydrogenase and the diagnosis of malaria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7038478" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Partial purification and characterization of lactate dehydrogenase from Plasmodium falciparum.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8447524" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Measurement of the lactate dehydrogenase activity of Plasmodium falciparum as an assessment of parasitemia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8333566" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9371095" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Plasmodium falciparum: evaluation of lactate dehydrogenase in monitoring therapeutic responses to standard antimalarial drugs in Nigeria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9988333" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Immunocapture diagnostic assays for malaria using Plasmodium lactate dehydrogenase (pLDH).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10929047" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Performance of the OptiMAL malaria antigen capture dipstick for malaria diagnosis and treatment monitoring at the Hospital for Tropical Diseases, London.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10929047" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Performance of the OptiMAL malaria antigen capture dipstick for malaria diagnosis and treatment monitoring at the Hospital for Tropical Diseases, London.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12174773" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Field and laboratory comparative evaluation of ten rapid malaria diagnostic tests.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17961215" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Evaluation of the intra- and inter-specific genetic variability of Plasmodium lactate dehydrogenase.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17961215" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Evaluation of the intra- and inter-specific genetic variability of Plasmodium lactate dehydrogenase.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15549388" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Co-reactivity of plasmodial histidine-rich protein 2 and aldolase on a combined immuno-chromographic-malaria dipstick (ICT) as a potential semi-quantitative marker of high Plasmodium falciparum parasitaemia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22920654" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Performance of "VIKIA Malaria Ag Pf/Pan" (IMACCESS®), a new malaria rapid diagnostic test for detection of symptomatic malaria infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17021060" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Assessing the genetic diversity of the aldolase genes of Plasmodium falciparum and Plasmodium vivax and its potential effect on performance of aldolase-detecting rapid diagnostic tests.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21087378" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Genetic variability in Plasmodium vivax aldolase gene in Korean isolates and the sensitivity of the Binax Now malaria test.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31791354" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : A review of the WHO malaria rapid diagnostic test product testing programme (2008-2018): performance, procurement and policy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31791354" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : A review of the WHO malaria rapid diagnostic test product testing programme (2008-2018): performance, procurement and policy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25519857" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22564504" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Malaria case management in Papua New Guinea prior to the introduction of a revised treatment protocol.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22564504" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Malaria case management in Papua New Guinea prior to the introduction of a revised treatment protocol.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19127977" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Abandoning presumptive antimalarial treatment for febrile children aged less than five years--a case of running before we can walk?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19127974" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Time to move from presumptive malaria treatment to laboratory-confirmed diagnosis and treatment in African children with fever.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19127974" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Time to move from presumptive malaria treatment to laboratory-confirmed diagnosis and treatment in African children with fever.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17407555" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Diagnosis and treatment of malaria in peripheral health facilities in Uganda: findings from an area of low transmission in south-western Uganda.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16950487" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Malaria treatment-seeking behaviour and drug prescription practices in an area of low transmission in Uganda: implications for prevention and control.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8888463" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Treatment seeking for malaria: a review of recent research.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20406492" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Can treatment of malaria be restricted to parasitologically confirmed malaria? A school-based study in Benin in children with and without fever.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20207689" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Rapid testing for malaria in settings where microscopy is available and peripheral clinics where only presumptive treatment is available: a randomised controlled trial in Ghana.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22198787" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Rapid diagnostic test-based management of malaria: an effectiveness study in Papua New Guinean infants with Plasmodium falciparum and Plasmodium vivax malaria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20642354" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Withholding antimalarials in febrile children who have a negative result for a rapid diagnostic test.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21978238" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Treatment guided by rapid diagnostic tests for malaria in Tanzanian children: safety and alternative bacterial diagnoses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21651827" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Community case management of malaria using ACT and RDT in two districts in Zambia: achieving high adherence to test results using community health workers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21320243" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Use of an HRP2-based rapid diagnostic test to guide treatment of children admitted to hospital in a malaria-endemic area of north-east Tanzania.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23144935" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Rapid antigen detection tests for malaria diagnosis in severely ill Papua New Guinean children: a comparative study using Bayesian latent class models.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21203389" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: a randomised controlled non-inferiority trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22859362" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Evaluation of antigen detection tests, microscopy, and polymerase chain reaction for diagnosis of malaria in peripheral blood in asymptomatic pregnant women in Nanoro, Burkina Faso.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26721833" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : The Performance of a Rapid Diagnostic Test in Detecting Malaria Infection in Pregnant Women and the Impact of Missed Infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26429700" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomised controlled superiority trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28820709" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Performance of a High-Sensitivity Rapid Diagnostic Test for Plasmodium falciparum Malaria in Asymptomatic Individuals from Uganda and Myanmar and Naive Human Challenge Infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31455349" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Field performance of the malaria highly sensitive rapid diagnostic test in a setting of varying malaria transmission.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30475992" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Prevalence and Epidemiological Characteristics of Asymptomatic Malaria Based on Ultrasensitive Diagnostics: A Cross-sectional Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35120441" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Performance and utility of more highly sensitive malaria rapid diagnostic tests.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14740873" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Evaluation of the Binax NOW ICT test versus polymerase chain reaction and microscopy for the detection of malaria in returned travelers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16216106" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Performance of the Now Malaria rapid diagnostic test with returned travellers: a 2-year retrospective study in a French teaching hospital.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19686072" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Diagnostic performance of rapid diagnostic tests versus blood smears for malaria in US clinical practice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22718936" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Performance of BinaxNOW for diagnosis of malaria in a U.S. hospital.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23135948" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Use of rapid diagnostic tests for diagnosis of malaria in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23135948" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Use of rapid diagnostic tests for diagnosis of malaria in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16010653" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : The current status and potential role of laboratory testing to prevent transfusion-transmitted malaria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9063360" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : Parasight F test compared with the polymerase chain reaction and microscopy for the diagnosis of Plasmodium falciparum malaria in travelers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11003728" id="rid109" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          110 : Use of dipstick tests for the rapid diagnosis of malaria in nonimmune travelers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23158019" id="rid110" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          111 : Safety of falciparum malaria diagnostic strategy based on rapid diagnostic tests in returning travellers and migrants: a retrospective study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10560678" id="rid111" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          112 : Self-use of rapid tests for malaria diagnosis by tourists.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11421381" id="rid112" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          113 : Self-testing for falciparum malaria with antigen-capture cards by travelers with symptoms of malaria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22034851" id="rid113" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          114 : Considerations on the use of nucleic acid-based amplification for malaria parasite detection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22034851" id="rid114" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          115 : Considerations on the use of nucleic acid-based amplification for malaria parasite detection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16930256" id="rid115" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          116 : Molecular genotyping to distinguish between recrudescents and new infections in treatment trials of Plasmodium falciparum malaria conducted in Sub-Saharan Africa: adjustment of parasitological outcomes and assessment of genotyping effectiveness.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17360872" id="rid116" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          117 : Low-level malaria infections detected by a sensitive polymerase chain reaction assay and use of this technique in the evaluation of malaria vaccines in an endemic area.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18801702" id="rid117" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          118 : Gametocytes: insights gained during a decade of molecular monitoring.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8479452" id="rid118" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          119 : Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20356398" id="rid119" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          120 : Evaluation of three PCR-based diagnostic assays for detecting mixed Plasmodium infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8944260" id="rid120" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          121 : Detection of malaria in Malaysia by nested polymerase chain reaction amplification of dried blood spots on filter papers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10348249" id="rid121" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          122 : A genus- and species-specific nested polymerase chain reaction malaria detection assay for epidemiologic studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8264734" id="rid122" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          123 : High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17223628" id="rid123" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          124 : Molecular epidemiology of malaria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21508150" id="rid124" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          125 : Cytochrome b gene quantitative PCR for diagnosing Plasmodium falciparum infection in travelers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22855751" id="rid125" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          126 : Emerging nucleic acid-based tests for point-of-care detection of malaria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8615441" id="rid126" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          127 : Detection of very low level Plasmodium falciparum infections using the nested polymerase chain reaction and a reassessment of the epidemiology of unstable malaria in Sudan.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11463112" id="rid127" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          128 : A field study on malaria prevalence in southeastern Laos by polymerase chain reaction assay.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12224567" id="rid128" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          129 : High prevalence of asymptomatic Plasmodium vivax and Plasmodium falciparum infections in native Amazonian populations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12057020" id="rid129" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          130 : Detection of malaria parasites by nested PCR in south-eastern, Iran: evidence of highly mixed infections in Chahbahar district.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19402894" id="rid130" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          131 : Towards high-throughput molecular detection of Plasmodium: new approaches and molecular markers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17360869" id="rid131" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          132 : Submicroscopic Plasmodium falciparum gametocyte densities frequently result in mosquito infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20027314" id="rid132" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          133 : Substantial contribution of submicroscopical Plasmodium falciparum gametocyte carriage to the infectious reservoir in an area of seasonal transmission.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22177014" id="rid133" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          134 : Association of sub-microscopic malaria parasite carriage with transmission intensity in north-eastern Tanzania.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21035842" id="rid134" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          135 : Shrinking the malaria map: progress and prospects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21035841" id="rid135" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          136 : Operational strategies to achieve and maintain malaria elimination.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22205884" id="rid136" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          137 : Estimating the burden of malaria: the need for improved surveillance.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22238621" id="rid137" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          138 : Surveillance for malaria elimination in Swaziland: a national cross-sectional study using pooled PCR and serology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10871386" id="rid138" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          139 : Loop-mediated isothermal amplification of DNA.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16339303" id="rid139" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          140 : Sensitive and inexpensive molecular test for falciparum malaria: detecting Plasmodium falciparum DNA directly from heat-treated blood by loop-mediated isothermal amplification.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23633405" id="rid140" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          141 : Highly sensitive detection of malaria parasitemia in a malaria-endemic setting: performance of a new loop-mediated isothermal amplification kit in a remote clinic in Uganda.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24795480" id="rid141" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          142 : Field evaluation of a real-time fluorescence loop-mediated isothermal amplification assay, RealAmp, for the diagnosis of malaria in Thailand and India.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28166235" id="rid142" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          143 : Development and clinical performance of high throughput loop-mediated isothermal amplification for detection of malaria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28982155" id="rid143" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          144 : Loop-mediated isothermal DNA amplification for asymptomatic malaria detection in challenging field settings: Technical performance and pilot implementation in the Peruvian Amazon.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17984362" id="rid144" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          145 : Loop-mediated isothermal PCR (LAMP) for the diagnosis of falciparum malaria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20595478" id="rid145" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          146 : Comparative diagnosis of malaria infections by microscopy, nested PCR, and LAMP in northern Thailand.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21976556" id="rid146" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          147 : Evaluation of loop-mediated isothermal amplification (LAMP) for malaria diagnosis in a field setting.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20554824" id="rid147" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          148 : Mitochondrial DNA targets increase sensitivity of malaria detection using loop-mediated isothermal amplification.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23633403" id="rid148" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          149 : Clinical evaluation of a loop-mediated amplification kit for diagnosis of imported malaria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28086789" id="rid149" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          150 : Detection of Plasmodium knowlesi, Plasmodium falciparum and Plasmodium vivax using loop-mediated isothermal amplification (LAMP) in a co-endemic area in Malaysia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29016335" id="rid150" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          151 : Performance of Loop-Mediated Isothermal Amplification for the Identification of Submicroscopic Plasmodium falciparum Infection in Uganda.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32659450" id="rid151" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          152 : Systematic review and meta-analysis of diagnostic accuracy of loop-mediated isothermal amplification (LAMP) methods compared with microscopy, polymerase chain reaction and rapid diagnostic tests for malaria diagnosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33670618" id="rid152" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          153 : Performance and Application of Commercially Available Loop-Mediated Isothermal Amplification (LAMP) Kits in Malaria Endemic and Non-Endemic Settings.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
